Juan C Ibla Selected Research

Juan C Ibla Research Topics

Disease

8	Hypoxia (Hypoxemia) 01/2022 - 09/2003
6	Thrombosis (Thrombus) 05/2023 - 01/2019
4	Hemorrhage 03/2022 - 01/2020
3	Carcinoma (Carcinomatosis) 12/2013 - 03/2013
2	Adenocarcinoma 10/2013 - 03/2013
2	Neoplasms (Cancer) 10/2013 - 03/2013
1	Protein Deficiency 01/2022
1	Anemia 01/2022
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Patent Ductus Arteriosus 01/2022
1	COVID-19 06/2021
1	Inflammation (Inflammations) 12/2020
1	Stroke (Strokes) 01/2020
1	Thrombotic Thrombocytopenic Purpura 03/2019
1	Thrombophilia 01/2018
1	Congenital Heart Defects (Congenital Heart Defect) 01/2018
1	Cyanosis 01/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016
1	Stomach Neoplasms (Stomach Cancer) 12/2013
1	Weight Gain 01/2009

Drug/Important Bio-Agent (IBA)

5	Adenosine (Adenocard)FDA LinkGeneric 05/2009 - 09/2003
3	von Willebrand FactorIBA 01/2022 - 03/2019
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2013
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 09/2003
2	Norisoprenoids (Irones)IBA 10/2013 - 03/2013
2	Adenine NucleotidesIBA 12/2004 - 09/2003
2	5'-Nucleotidase (5' Nucleotidase)IBA 12/2004 - 12/2004
2	Adenosine Triphosphate (ATP)IBA 12/2004 - 09/2003
1	CoagulantsIBA 05/2023
1	Heme (Haem)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Cyclophilins (Cyclophilin)IBA 06/2021
1	Blood Coagulation Factors (Coagulation Factor)IBA 06/2021
1	Antiviral Agents (Antivirals)IBA 06/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2021
1	AntigensIBA 12/2020
1	Hemostatics (Antihemorrhagics)IBA 01/2020
1	thiamine triphosphorate (TTP)IBA 03/2019
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2016
1	Small Interfering RNA (siRNA)IBA 12/2013
1	Mitogen-Activated Protein KinasesIBA 10/2013
1	DNA (Deoxyribonucleic Acid)IBA 10/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2013
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 05/2009
1	NF-KappaB Inhibitor alphaIBA 05/2009
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2009
1	Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA 05/2009
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2009
1	Ketamine FDA LinkGeneric 01/2009
1	NF-kappa B (NF-kB)IBA 03/2007
1	Complementary DNA (cDNA)IBA 03/2007
1	Member 2 Solute Carrier Family 12IBA 08/2006
1	Adenosine Monophosphate (AMP)IBA 12/2004
1	NucleotidesIBA 12/2004
1	Adenosine Diphosphate (ADP)IBA 12/2004
1	Purinergic P1 Receptor AgonistsIBA 12/2004
1	Adenosine A2B ReceptorIBA 09/2003
1	Oxygen (Dioxygen)IBA 09/2003
1	NucleosidesIBA 09/2003

Therapy/Procedure

3	Platelet Transfusion (Blood Platelet Transfusions) 03/2022 - 01/2022
2	Rewarming 03/2022 - 01/2022
2	Therapeutics 03/2022 - 01/2022
1	Length of Stay 01/2023
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022
1	Cardiac Surgical Procedures 01/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	High-Frequency Ventilation 01/2022